SCHEMBL7784706

SCHEMBL7784706

Cc1ccc(Cl)c([N+](=O)[O-])c1[N+](=O)[O-]

nearest known ligand 0.56

Predicted protein targets (top 14)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 6/20 0.56
TDP1 Q9NUW8 3/20 0.56
TSHR P16473 8/20 0.48
CYP3A4 P08684 3/20 0.43
HSD17B10 Q99714 2/20 0.42
TNF P01375 1/20 0.38
RECQL P46063 1/20 0.38
GRIN2D O15399 1/20 0.38
GRIN3B O60391 1/20 0.38
GRIN1 Q05586 1/20 0.38
GRIN2A Q12879 1/20 0.38
GRIN2B Q13224 1/20 0.38
GRIN2C Q14957 1/20 0.38
GRIN3A Q8TCU5 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4427648 0.86 ALDH1A1 (0.71) ALDH1A1TDP1TSHRCYP3A4HSD17B10
SCHEMBL7514813 0.86 ALDH1A1 (0.56) ALDH1A1TDP1TSHRCYP3A4HSD17B10
SCHEMBL29702010 0.86 ALDH1A1 (0.56) ALDH1A1TDP1TSHRCYP3A4HSD17B10
SCHEMBL3864389 0.85 TSHR (0.48) ALDH1A1TDP1TSHRCYP3A4HSD17B10
SCHEMBL10420952 0.85 ALDH1A1 (0.48) ALDH1A1TDP1TSHRCYP3A4HSD17B10
SCHEMBL3860827 0.85 TSHR (0.54) ALDH1A1TDP1TSHRCYP3A4HSD17B10
SCHEMBL2143287 0.85 ALDH1A1 (0.54) ALDH1A1TDP1TSHRCYP3A4HSD17B10
SCHEMBL31569522 0.82 ALDH1A1 (0.45) ALDH1A1TDP1TSHRCYP3A4HSD17B10
SCHEMBL28187713 0.82 ALDH1A1 (0.50) ALDH1A1TDP1TSHRCYP3A4HSD17B10
SCHEMBL27481885 0.82 ALDH1A1 (0.45) ALDH1A1TDP1TSHRCYP3A4HSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6251903-B1 Alkyl, azido, alkoxy, and fluoro-substituted and fused quinoxalinediones and the use thereof as glycine receptor antagonist COCENSYS, INC. 2001-06-26 US disclosed
US-6147075-A ANALGESICS; PSYCHOLOGICAL DISORDERS COCENSYS, INC. (US) 2000-11-14 US disclosed
EP-0732942-A4 ALKYL, AZIDO, ALKOXY, AND FLUORO-SUBSTITUTED AND FUSED QUINOXALINEDIONES AND THE USE THEREOF AS GLYCINE RECEPTOR ANTAGONISTS COCENSYS INC (US) 2000-03-22 EP disclosed
US-5977107-A Alkyl, azido, alkoxy, and fluoro-substituted and fused quinoxalinediones and the use thereof as glycine receptor antagonists COCENSYS, INC. (US) 1999-11-02 US disclosed
US-5631373-A NERVOUS SYSTEM DISORDERS STATE OF OREGON, ACTING BY AND THROUGH THE OREGON STATE BOARD OF HIGHER EDUCATION, ACTING FOR AND ON BEHALF OF THE OREGON HEALTH SCIENCES UNIVERSITY AND THE UNIVERSITY OF OREGON, EUGENE OREGON (US) 1997-05-20 US disclosed
EP-0732942-A1 ALKYL, AZIDO, ALKOXY, AND FLUORO-SUBSTITUTED AND FUSED QUINOXALINEDIONES AND THE USE THEREOF AS GLYCINE RECEPTOR ANTAGONISTS ACEA PHARMACEUTICALS, INC. (US) 1996-09-25 EP disclosed
WO-1995012417-A1 ALKYL, AZIDO, ALKOXY, AND FLUORO-SUBSTITUTED AND FUSED QUINOXALINEDIONES AND THE USE THEREOF AS GLYCINE RECEPTOR ANTAGONISTS ACEA PHARMACEUTICALS, INC. (US) 1995-05-11 WO disclosed